JPH029398A - 悪性胸部疾患の診断法及び診断用キット - Google Patents

悪性胸部疾患の診断法及び診断用キット

Info

Publication number
JPH029398A
JPH029398A JP1058063A JP5806389A JPH029398A JP H029398 A JPH029398 A JP H029398A JP 1058063 A JP1058063 A JP 1058063A JP 5806389 A JP5806389 A JP 5806389A JP H029398 A JPH029398 A JP H029398A
Authority
JP
Japan
Prior art keywords
dna
amplification
human
gene
samples
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1058063A
Other languages
English (en)
Japanese (ja)
Inventor
Jennifer Margaret Varley
ジエニフアー・マーガレツト・ヴアーレイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Leicester
Imperial Chemical Industries Ltd
Original Assignee
University of Leicester
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888805807A external-priority patent/GB8805807D0/en
Priority claimed from GB888807392A external-priority patent/GB8807392D0/en
Application filed by University of Leicester, Imperial Chemical Industries Ltd filed Critical University of Leicester
Publication of JPH029398A publication Critical patent/JPH029398A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP1058063A 1988-03-11 1989-03-13 悪性胸部疾患の診断法及び診断用キット Pending JPH029398A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8805807 1988-03-11
GB888805807A GB8805807D0 (en) 1988-03-11 1988-03-11 Diagnostic method
GB8807392.9 1988-03-29
GB888807392A GB8807392D0 (en) 1988-03-29 1988-03-29 Diagnostic method

Publications (1)

Publication Number Publication Date
JPH029398A true JPH029398A (ja) 1990-01-12

Family

ID=26293618

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1058063A Pending JPH029398A (ja) 1988-03-11 1989-03-13 悪性胸部疾患の診断法及び診断用キット

Country Status (5)

Country Link
JP (1) JPH029398A (it)
DE (1) DE3907824A1 (it)
FR (1) FR2628441A1 (it)
GB (1) GB2217450A (it)
IT (1) IT1229565B (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5598534B2 (ja) * 2010-03-09 2014-10-01 株式会社村田製作所 Ｎｉ−Ｍｏめっき膜及びその製造方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2479292A (en) * 1991-08-12 1993-03-16 Board Of Regents, The University Of Texas System Methods and compositions for the detection and prediction of breast cancer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5598534B2 (ja) * 2010-03-09 2014-10-01 株式会社村田製作所 Ｎｉ−Ｍｏめっき膜及びその製造方法

Also Published As

Publication number Publication date
DE3907824A1 (de) 1989-09-21
IT1229565B (it) 1991-09-04
GB8905528D0 (en) 1989-04-19
IT8919719A0 (it) 1989-03-10
GB2217450A (en) 1989-10-25
FR2628441A1 (fr) 1989-09-15

Similar Documents

Publication Publication Date Title
Nilbert et al. Characterization of the 12q13-15 amplicon in soft tissue tumors
Press et al. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.
Berger et al. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading
Garcia et al. Genetic alterations of c-myc, c-erb B-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas
Schalken et al. fur gene expression as a discriminating marker for small cell and nonsmall cell lung carcinomas.
Popescu et al. Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12–21.32
Dati et al. c‐erbB‐2 and ras expression levels in breast cancer are correlated and show a co‐operative association with unfavorable clinical outcome
Sato et al. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung
Heerdt et al. Expression of mitochondrial cytochrome c oxidase in human colonic cell differentiation, transformation, and risk for colonic cancer
Merlo et al. Frequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas
Fey et al. Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe.
Mackay et al. Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level
Challen et al. Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas
Morita et al. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression
Sugio et al. Differential expression of c-myc gene and c-fos gene in premalignant and malignant tissues from patients with familial polyposis coli
Bogen et al. The genetic tumor background is an important determinant for heterogeneous MYCN‐amplified neuroblastoma
O'Connell et al. Fine structure DNA mapping studies of the chromosomal region harboring the genetic defect in neurofibromatosis type 1
Ireland Activated N-ras oncogenes in human neuroblastoma
Meyers et al. Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas
Deng et al. Activated c-Ha-ras oncogene with a guanine to thymine transversion at the twelfth codon in a human stomach cancer cell line
Willeke et al. Detection of SYT–SSX1/2 fusion transcripts by reverse transcriptase–polymerase chain reaction (RT–PCR) is a valuable diagnostic tool in synovial sarcoma
White et al. DNA alterations in prostatic adenocarcinoma and benign prostatic hyperplasia: detection by DNA fingerprint analyses
Fischer et al. Risk estimation of neuroblastoma patients using molecular markers
JPH029398A (ja) 悪性胸部疾患の診断法及び診断用キット
Richardson et al. Genetic alterations in the 61st codon of the H-ras oncogene isolated from archival sections of hepatic hyperplasias, adenomas and carcinomas in control groups of B6C3F1 mouse bioassay studies conducted from 1979 to 1986